PEO is from August 1th 2012 exclusive distributor of Ashland’s RAD-SURE

PEO is from August 1th 2012 exclusive distributor of Ashland’s RAD-SURE for visual indicators for irradiation control against Transfusion-associated graft-versus-host disease (TA-GVHD)

Transfusion-associated graft-versus-host disease (TA-GVHD), a rare complication of blood transfusion, is usually fatal. Patients in certain clinical categories, including bone marrow transplants, solid tumors and acquired T cell defects, are at greater risk of developing TA-GVHD.  TA-GVHD can be prevented by the irradiation of cellular blood products prior to transfusion.

This results to a decrease of 90% in death rate of TA-GVHD!

RAD-SURE blood irradiation indicators provide positive, visual verification of irradiation. When attached to blood products, indicators show whether the blood products have been irradiated or not.

The indicators are available for gamma and x-ray in 15 and 25 Gy.
Also there is an UVA version () available.

advantages

  • Easy to use
  • Easy to interpret before & after irradiation; visual message NOT IRRADIATED to IRRADIATED
  • Environmentally stable to temperature, light exposure & water immersion
  • 18 months expiry date
  • Optional: UVA indicators ()

scope

  • Blood transfusion QA

characteristics

  • Temperature indication QA
  • FDA registered
  • CE marked
  • 20 years active on the market
  • Tens of millions units used

Would you like to know more about Ashland’s RAD-SURE?
View the brochure () or contact PEO tel. +31 24 648 86 88.

Ashland RAD-SURE brochure

(

)

{youtube}bXbEC6g6cc0|200|150|0{/youtube}

ash_12_radsure2

More information?

Share this article

https://peomedical.com/news/peo-is-since-august-1th-2012-exclusive-distributor-of-ashlands-radsure/

Copy link
Email WhatsApp WhatsApp LinkedIn